March 15, 2025 09:24 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mark Carney takes oath as new Canada Prime Minister | Man attacks people with iron rod inside Golden Temple in Amritsar, leaves 5 injured | Not disrespectful: Tamilian who designed rupee symbol reacts to Stalin govt's currency move | In a setback for Donald Trump, US judge orders federal agencies to rehire fired workers: Report | 'We will thwart conspiracies hatched by Centre': Revanth Reddy on delimitation exercise | Chennai doctor, his wife along with two sons die by suicide due to huge debt: Cops | Amid language debate, Tamil Nadu drops rupee symbol in state budget | Scientist killed in assault by neighbour over parking argument in Mohali | British woman tourist raped in Delhi hotel by man she befriended on social media | Gold smuggling case: Court restrains media from publishing, telecasting defamatory statements against Ranya Rao

Cipla promoters sell 2.53% stake in company for Rs 2,637 cr

May 15, 2024, at 10:18 pm

Mumbai: The promoters of Cipla have sold a 2.53% stake in the company for 'creating liquidity' for specific needs including 'philanthropy', the Mumbai headquartered pharma major said on Wednesday.

Cipla Q4FY24: Net profit grows 79% YoY to Rs 939 cr

May 10, 2024, at 10:21 pm

Mumbai: Pharma giant Cipla’s consolidated net profit grew 79% rising to Rs 939.04 crore in Q4 FY24 over Q4 FY23.

Sanofi partners with Cipla to distribute and promote its Central Nervous System product range in India

Mar 27, 2024, at 06:16 am

Mumbai: Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India.

Cipla's portable, wireless spirometer to ease diagnosis of COPD, asthma

Nov 17, 2021, at 02:37 pm

Mumbai/IBNS: Indian multinational pharma giant Cipla Limited  (BSE:  500087;  NSE:  CIPLA  EQ)  Wednesday announced  the launch  of  Spirofy, India's first pneumotach based portable, wireless spirometer, on World COPD Day, the company said in a BSE filing.

Cinacalcet tablets case: Cipla, Amgen settle legal dispute

Jul 20, 2020, at 10:45 pm

Mumbai/UNI: Pharma major, Cipla on Monday said company has settled a a legal dispute with Amgen in the United States involving generic cinacalcet hydrochloride tablets , used in treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease.

Close menu